We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.11B
AUM Growth
+$140M
(+4.7%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,199
Closed
259
Avg Time Held Equity + Options
3.7
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2.5
years
Avg Time Held Equity only
3.7
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$72.4M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$18.9M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$9.7M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$3.85M |
| 5 |
Confluent
CFLT
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$39.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$19.1M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.1M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$16.4M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.46% |
| 2 | Technology | 15.44% |
| 3 | Healthcare | 8.51% |
| 4 | Financials | 6.64% |
| 5 | Consumer Discretionary | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
Seacoast Banking Corp of Florida
SBCF
$3.14B
| $825 | ﹤0.01% |
37
-376
| -91% | -$8.17K |
2022 Q2
4 quarters
|
|
2977
Array Technologies
ARRY
$545M
| $814 | ﹤0.01% |
36
| – | – |
2021 Q2
8 quarters
|
|
2978
ACI Worldwide
ACIW
$5.22B
| $811 | ﹤0.01% |
35
-153
| -81% | -$3.7K |
2021 Q2
8 quarters
|
|
2979
Cannae Holdings
CNNE
$696M
| $808 | ﹤0.01% |
40
-214
| -84% | -$4.11K |
2019 Q1
17 quarters
|
|
|
KDNY
2980
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $807 | ﹤0.01% |
26
-31
| -54% | -$796 |
2019 Q2
16 quarters
|
|
2981
Materion
MTRN
$5.18B
| $799 | ﹤0.01% |
7
| – | – |
2022 Q3
3 quarters
|
|
2982
First Bancorp
FBNC
$2.5B
| $798 | ﹤0.01% |
26
-66
| -72% | -$2.09K |
2020 Q2
12 quarters
|
|
2983
Green Brick Partners
GRBK
$2.65B
| $795 | ﹤0.01% |
+14
| New | +$652 |
2023 Q2
0 quarters
|
|
2984
Evotec
EVO
$501M
| $791 | ﹤0.01% |
70
| – | – |
2022 Q1
5 quarters
|
|
|
SONX
2985
DELISTED
Sonendo, Inc.
SONX
| $791 | ﹤0.01% |
581
| – | – |
2022 Q1
5 quarters
|
|
2986
Digi International
DGII
$2.66B
| $788 | ﹤0.01% |
20
| – | – |
2022 Q3
3 quarters
|
|
2987
Old Second Bancorp
OSBC
$1.27B
| $786 | ﹤0.01% |
60
-133
| -69% | -$1.69K |
2017 Q3
23 quarters
|
|
2988
Hope Bancorp
HOPE
$1.71B
| $782 | ﹤0.01% |
92
+1
| +1% | +$9 |
2019 Q4
14 quarters
|
|
2989
Tarsus Pharmaceuticals
TARS
$3.24B
| $777 | ﹤0.01% |
+43
| New | +$684 |
2023 Q2
0 quarters
|
|
2990
Aimco
AIV
$241M
| $775 | ﹤0.01% |
91
-1,293
| -93% | -$10.5K |
2016 Q4
26 quarters
|
|
2991
Monarch Casino & Resort
MCRI
$2.05B
| $775 | ﹤0.01% |
11
-19
| -63% | -$1.33K |
2023 Q1
1 quarter
|
|
2992
FTAI Aviation
FTAI
$17.3B
| $768 | ﹤0.01% |
+24
| New | +$680 |
2023 Q2
0 quarters
|
|
2993
Editas Medicine
EDIT
$366M
| $765 | ﹤0.01% |
93
| – | – |
2022 Q2
4 quarters
|
|
2994
TaskUs
TASK
$757M
| $758 | ﹤0.01% |
67
-9
| -12% | -$109 |
2022 Q4
2 quarters
|
|
|
HELP
2995
Helus Pharma Inc. Common Stock
HELP
$770M
| $756 | ﹤0.01% |
53
| – | – |
2023 Q1
1 quarter
|
|
|
VRTV
2996
DELISTED
VERITIV CORPORATION
VRTV
| $754 | ﹤0.01% |
+6
| New | +$702 |
2023 Q2
0 quarters
|
|
2997
Bloomin' Brands
BLMN
$842M
| $753 | ﹤0.01% |
+28
| New | +$701 |
2023 Q2
0 quarters
|
|
2998
AngioDynamics
ANGO
$473M
| $751 | ﹤0.01% |
72
+17
| +31% | +$164 |
2020 Q1
13 quarters
|
|
|
CFMS
2999
DELISTED
Conformis, Inc. Common Stock
CFMS
| $747 | ﹤0.01% |
341
| – | – |
2022 Q4
2 quarters
|
|
3000
Celldex Therapeutics
CLDX
$2.2B
| $746 | ﹤0.01% |
22
-2
| -8% | -$67 |
2022 Q2
4 quarters
|
|
Similar funds
Parallel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,199 reduced and 259 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
- Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
- Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
- Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
- Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
- Parallel Advisors opened 197 new positions and closed 259 in Q2 2023.
- Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.
Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.